SC 13D/A

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Company: Milestone Pharmaceuticals Inc.
Filed: July 16, 2024
Accession Number: 0000921895-24-001575

View Document ↗ View on SEC.gov ↗